EU Council Agrees Compromise Position On Joint Clinical Assessments
Industry Split On Whether It’s Progress Or A Letdown
The Alliance For Regenerative Medicines is calling for advanced therapies to be given greater priority where joint clinical assessments are concerned.
You may also be interested in...
Pharma industry representatives are calling for the proposals on health technology assessment cooperation to include more flexibility on uncertainty in evidence supporting orphans and advanced therapies.
Legislation that would introduce EU-wide joint clinical assessments has moved a step forward after the European Parliament adopted its version of the proposals.
Plans from the European Commission that would oblige all EU member states to consider joint clinical assessments have come under fire from Germany, France, Poland and the Czech Republic.